BEACON INVESTMENT ADVISORY SERVICES, INC. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.

Quarter-by-quarter ownership
BEACON INVESTMENT ADVISORY SERVICES, INC. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$37,680
-39.1%
12,0000.0%0.00%
-33.3%
Q2 2023$61,920
-2.1%
12,0000.0%0.00%0.0%
Q1 2023$63,240
+87.5%
12,0000.0%0.00%
+50.0%
Q4 2022$33,720
-32.6%
12,0000.0%0.00%
-33.3%
Q3 2022$50,000
+4.2%
12,0000.0%0.00%0.0%
Q2 2022$48,000
-18.6%
12,0000.0%0.00%0.0%
Q1 2022$59,000
-29.8%
12,0000.0%0.00%0.0%
Q4 2021$84,000
-30.0%
12,0000.0%0.00%
-40.0%
Q3 2021$120,000
-29.4%
12,0000.0%0.01%
-28.6%
Q2 2021$170,000
-13.7%
12,0000.0%0.01%
-22.2%
Q1 2021$197,000
-4.8%
12,000
+20.0%
0.01%
-10.0%
Q4 2020$207,000
+172.4%
10,0000.0%0.01%
+150.0%
Q3 2020$76,000
-8.4%
10,0000.0%0.00%
-20.0%
Q2 2020$83,000
+66.0%
10,0000.0%0.01%
+25.0%
Q1 2020$50,000
+25.0%
10,0000.0%0.00%
+100.0%
Q4 2019$40,00010,0000.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2020
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders